Lania Andrea G, Mantovani Giovanna, Ferrero Stefano, Pellegrini Caterina, Bondioni Sara, Peverelli Erika, Braidotti Paola, Locatelli Marco, Zavanone Mario L, Ferrante Emanuela, Bosari Silvano, Beck-Peccoz Paolo, Spada Anna
Institute of Endocrine Sciences, Ospedale Maggiore, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Cancer Res. 2004 Dec 15;64(24):9193-8. doi: 10.1158/0008-5472.CAN-04-1847.
The two regulatory subunits (R1 and R2) of protein kinase A (PKA) are differentially expressed in cancer cell lines and exert diverse roles in growth control. Recently, mutations of the PKA regulatory subunit 1A gene (PRKAR1A) have been identified in patients with Carney complex. The aim of this study was to evaluate the expression of the PKA regulatory subunits R1A, R2A, and R2B in a series of 30 pituitary adenomas and the effects of subunit activation on cell proliferation. In these tumors, neither mutation of PRKAR1A nor loss of heterozygosity was identified. By real-time PCR, mRNA of the three subunits was detected in all of the tumors, R1A being the most represented in the majority of samples. By contrast, immunohistochemistry documented low or absent R1A levels in all tumors, whereas R2A and R2B were highly expressed, thus resulting in an unbalanced R1/R2 ratio. The low levels of R1A were, at least in part, due to proteasome-mediated degradation. The effect of the R1/R2 ratio on proliferation was assessed in GH3 cells, which showed a similar unbalanced pattern of R subunits expression, and in growth hormone-secreting adenomas. The R2-selective cAMP analog 8-Cl cAMP and R1A RNA silencing, stimulated cell proliferation and increased Cyclin D1 expression, respectively, in human and rat adenomatous somatotrophs. These data show that a low R1/R2 ratio promoted proliferation of transformed somatotrophs and are consistent with the Carney complex model in which R1A inactivating mutations further unbalance this ratio in favor of R2 subunits. These results suggest that low expression of R1A protein may favor cAMP-dependent proliferation of transformed somatotrophs.
蛋白激酶A(PKA)的两个调节亚基(R1和R2)在癌细胞系中差异表达,并在生长控制中发挥不同作用。最近,在卡尼综合征患者中发现了PKA调节亚基1A基因(PRKAR1A)的突变。本研究的目的是评估30例垂体腺瘤中PKA调节亚基R1A、R2A和R2B的表达情况以及亚基激活对细胞增殖的影响。在这些肿瘤中,未发现PRKAR1A突变或杂合性缺失。通过实时PCR,在所有肿瘤中均检测到这三个亚基的mRNA,其中R1A在大多数样本中表达最多。相比之下,免疫组化显示所有肿瘤中R1A水平较低或缺失,而R2A和R2B高度表达,从而导致R1/R2比例失衡。R1A水平较低至少部分是由于蛋白酶体介导的降解。在GH3细胞(其显示出类似的R亚基表达失衡模式)和生长激素分泌型腺瘤中评估了R1/R2比例对增殖的影响。R2选择性cAMP类似物8-Cl cAMP和R1A RNA沉默分别在人和大鼠腺瘤性生长激素细胞中刺激细胞增殖并增加细胞周期蛋白D1的表达。这些数据表明,低R1/R2比例促进了转化生长激素细胞的增殖,并且与卡尼综合征模型一致,在该模型中R1A失活突变进一步使该比例失衡,有利于R2亚基。这些结果表明,R1A蛋白的低表达可能有利于转化生长激素细胞的cAMP依赖性增殖。